C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 7,654 | 20,078 | 8,500 | 9,781 | 7,426 |
| Gross Profit | 7,654 | 20,078 | 8,500 | 9,781 | 7,426 |
| Operating Expenses | 39,023 | 35,333 | 32,754 | 31,897 | 27,935 |
| Operating Income | -31,369 | -15,255 | -24,254 | -22,116 | -20,509 |
| Interest Expense | 527 | 293 | 539 | 464 | 462 |
| Other Income | 276 | -110 | 110 | 0 | 0 |
| Pre-tax Income | -31,620 | -15,658 | -24,683 | -22,580 | -20,971 |
| Net Income Continuous | -31,620 | -15,658 | -24,683 | -22,580 | -20,971 |
| Net Income | $-31,620 | $-15,658 | $-24,683 | $-22,580 | $-20,971 |
| EPS Basic Total Ops | -0.65 | -0.31 | -0.51 | -0.51 | -0.49 |
| EPS Basic Continuous Ops | -0.65 | -0.31 | -0.51 | -0.51 | -0.49 |
| EPS Diluted Total Ops | -0.65 | -0.31 | -0.51 | -0.51 | -0.49 |
| EPS Diluted Continuous Ops | -0.65 | -0.31 | -0.51 | -0.51 | -0.49 |
| EBITDA(a) | $-30,224 | $-13,906 | $-23,186 | $-21,178 | $-19,774 |